-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $95

Benzinga·07/16/2026 15:59:36
语音播报
Truist Securities analyst Richard Newitter maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $90 to $95.